BELLINI trial
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
BELLINI trial
Sep 27, 2024, 16:31 |
Insight
Immunotherapy for aggressive breast cancer appears to be effective even without chemotherapy - The Netherlands Cancer Institute
The Netherlands Cancer Institute posted on LinkedIn: "Immunotherapy as a treatment for an aggressive form of…
Sep 20, 2024, 08:16 |
Blog
Yakup Ergün: Nivolumab/Relatlimab or Nivolumab/Ipilimumab in TNBC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in…
Apr 18, 2024, 13:58 |
Insight
Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma
Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…
All:
3
Posts:
1 - 100
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Inside OncoDaily Party Barcelona
Zainab Shinkafi-Bagudu has been elected as UICC President-Elect 2024-2026
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube